3M Company (MMM) Stock Forecast
Data as of May 2, 2026Industrials · Current price $142.65 (-2.64%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 21, 2026 | Brett Linzey | Mizuho Securities | $160.00 | +12.2% |
| Jan 21, 2026 | Deane Dray | RBC Capital | $136.00 | -4.7% |
| Jan 15, 2026 | Deane Dray | RBC Capital | $131.00 | -8.2% |
| Dec 8, 2025 | Nicole Deblase | Deutsche Bank | $178.00 | +24.8% |
| Oct 22, 2025 | Amit Mehrotra | UBS | $190.00 | +33.2% |
| Oct 22, 2025 | Julian Mitchell | Barclays | $180.00 | +26.2% |
| Jul 18, 2025 | Julian Mitchell | Barclays | $170.00 | +19.2% |
| Jul 18, 2025 | Stephen Tusa | J.P. Morgan | $167.00 | +17.1% |
| Nov 12, 2024 | Markus Mittermaier | UBS | $184.00 | +29.0% |
| Oct 23, 2024 | Andrew Obin | Bank of America Securities | $160.00 | +12.2% |
| Oct 23, 2024 | Deane Dray | RBC Capital | $100.00 | -29.9% |
| Oct 22, 2024 | Jonathan Sakraida | CFRA | $165.00 | +15.7% |
| Oct 22, 2024 | Andrew Kaplowitz | Citigroup | $133.00 | -6.8% |
| Oct 16, 2024 | Brett Linzey | Mizuho Securities | $146.00 | +2.4% |
| Oct 2, 2024 | Julian Mitchell | Barclays | $160.00 | +12.2% |
| Sep 24, 2024 | Laurence Alexander | Jefferies | $146.00 | +2.4% |
| Sep 6, 2024 | Christopher Snyder | Morgan Stanley | $125.00 | -12.4% |
| Jul 31, 2024 | Nicole Deblase | Deutsche Bank | $150.00 | +5.2% |
| Jul 30, 2024 | John Eade | Argus Research | $145.00 | +1.7% |
| Jul 29, 2024 | Deane Dray | RBC Capital | $95.00 | -33.4% |
Top Analysts Covering MMM
MMM vs Sector & Market
| Metric | MMM | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.77 | 2.41 | 2.41 |
| Analyst Count | 13 | 8 | 18 |
| Target Upside | +16.9% | +84.9% | +14.9% |
| P/E Ratio | 27.48 | 28.15 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $24.86B | $25.09B | $25.78B | 10 |
| 2027-03-31 | $6.15B | $6.18B | $6.22B | 3 |
| 2027-06-30 | $6.54B | $6.57B | $6.62B | 3 |
| 2027-09-30 | $6.67B | $6.71B | $6.76B | 3 |
| 2027-12-31 | $6.38B | $6.41B | $6.46B | 3 |
| 2028-03-31 | $6.00B | $6.03B | $6.08B | 2 |
| 2028-06-30 | $6.00B | $6.03B | $6.08B | 2 |
| 2028-09-30 | $6.01B | $6.04B | $6.08B | 2 |
| 2028-12-31 | $6.01B | $6.04B | $6.08B | 2 |
| 2029-12-31 | $27.71B | $27.97B | $28.56B | 5 |
| 2030-12-31 | $28.21B | $28.48B | $29.08B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $8.59 | $8.69 | $8.95 | 10 |
| 2027-03-31 | $2.17 | $2.18 | $2.20 | 3 |
| 2027-06-30 | $2.43 | $2.45 | $2.47 | 5 |
| 2027-09-30 | $2.57 | $2.59 | $2.61 | 3 |
| 2027-12-31 | $2.18 | $2.20 | $2.22 | 6 |
| 2028-03-31 | $2.36 | $2.38 | $2.40 | 4 |
| 2028-06-30 | $2.66 | $2.68 | $2.71 | 6 |
| 2028-09-30 | $2.78 | $2.80 | $2.83 | 4 |
| 2028-12-31 | $2.37 | $2.39 | $2.41 | 7 |
| 2029-12-31 | $11.09 | $11.22 | $11.53 | 1 |
| 2030-12-31 | $12.10 | $12.25 | $12.59 | 1 |
Frequently Asked Questions
What is the analyst consensus for MMM?
The consensus among 13 analysts covering 3M Company (MMM) is Hold with an average price target of $169.50.
What is the highest price target for MMM?
The highest price target for MMM is $195.00, set by John Walsh at Credit Suisse on 2022-01-26.
What is the lowest price target for MMM?
The lowest price target for MMM is $78.00, set by Deane Dray at RBC Capital on 2024-04-02.
How many analysts cover MMM?
13 analysts have issued ratings for 3M Company in the past 12 months.
Is MMM a buy or sell right now?
Based on 13 analyst ratings, MMM has a consensus rating of Hold (2.77/5) with a +16.9% upside to the consensus target of $169.50.
What are the earnings estimates for MMM?
Analysts estimate MMM will report EPS of $8.69 for the period ending 2026-12-31, with revenue estimated at $25.09B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.